The FDA actually wants to know
 Loading
|
Take control of your epilepsy and seizures. Seizure management has never been easier.
TAKE CONTROL TODAYIn 2000, oxcarbazepine was approved by the U.S. Food and Drug Administration (FDA) for the treatment of partial seizures. It is approved for use as either monotherapy or adjunctive therapy for adults and children as young as 4 years of age.
As the name suggests, oxcarbazepine is related to carbamazepine (Tegretol, Carbatrol) and appears to be similarly effective for controlling complex partial seizures and primary and secondarily generalized tonic-clonic seizures. It seems to cause fewer unwanted side effects in many (but not all) patients.
Oxcarbazepine is not effective against absence or myoclonic seizures.
Reviewed by Steven C. Schachter, MD
Submitted: 01/03/08
Welcome to the Wiki. This space is created for epilepsy.com members to share their own experiences and expertise to help refine and expand the discussion around important topics.
No members have yet contributed to this topic. If you are not yet an epilepsy.com member, register today to get started on this Wiki topic and the many other advantages of being a member. If you are a member and wish to be the first to edit this Wiki topic, please make sure to login, then click on the orange "Start Wiki" button at the top of this page. Or, learn more about Wikis.
 NewJersey |
peterg... |
budsbabe Epilepsy Medications Triggering Ocular Migraines
Created by budsbabeat6/28/08 - 10:39 am|3 Comments Posted To: |
EmmasDad FDA not giving approval to Emfit for nighttime bed seizure alarm?
Created by EmmasDadat3/5/08 - 4:06 pm|5 Comments Posted To: |